Maintenance therapy with carfilzomib, pomalidomide, and dexamethasone (KPd) in highrisk myeloma patients (pts): A phase 2 study with a safety run-in

Category Primary study
JournalJournal of Clinical Oncology
Year 2023
This article has no abstract
Epistemonikos ID: 61a0b9670ce7900e2a94556b9282f0861f213a49
First added on: Feb 16, 2025